Randomized Study of Obicetrapib as an Adjunct to Statin Therapy

NCT04753606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias
High Cholesterol
Hypercholesterolemia

Interventions

DRUG: Obicetrapib

Sponsor

NewAmsterdam Pharma